Back

XLV Stock

Price Chart

📈
Loading chart for XLV...
Powered by TradingView

Detailed Market Analysis

Key Levels

Support
$139.47
Resistance
$154.15

Volume & Momentum

Volume
Weak
0.8x avg
Momentum
0%
Weak

Trading Setup

HOLD
Entry $146.81
Stop $139.47
Target $154.15
RSI: 50 | Current: $146.81

Market Sentiment

50
Neutral

Stock Metrics

Daily Vol
0%
VIX Est
20
Weekly
0%

XLV News Intelligence (3 articles)

AI-curated news influencing XLV price, sentiment, and trend

Explore All XLV News with AI Analysis
Economy
2 hours, 8 minutes ago

1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the …

Impact on XLV: The healthcare sector's flat return over the past six months, compared to …
The healthcare sector has shown resilience with a flat return over the past six months, … High (70%)
View full analysis →
Yahoo Finance 70% confidence
Economy
4 days, 11 hours ago

1 Healthcare Stock on Our Watchlist and 2 We Find Risky

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory …

Impact on XLV: The 2.2% decline in the healthcare industry has mirrored the S&P 500's …
The healthcare industry has experienced a 2.2% decline over the past six months, mirroring the … High (70%)
View full analysis →
Yahoo Finance 70% confidence
Stocks
2 weeks, 2 days ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Pharmaceutical giant Pfizer and French partner Valneva on Monday said they planned to seek regulatory approval for a Lyme disease …

Impact on XLV: The announcement is likely to have a positive impact on Pfizer's (PFE) …
Pfizer and Valneva plan to seek regulatory approval for a Lyme disease vaccine after a … High (80%)
View full analysis →
MarketWatch 80% confidence
🤖

AI Analysis

Multi-Provider AI Analysis

Neutral

AI Summary

Loading...

Confidence
0%
AI Model Multi-Provider AI Analysis
Open article